Nanollose raises $1.58m through option conversions
By nanollose in Media
Ragtrader – 6 May 2026
ASX-listed biomaterials company Nanollose (NC6) has secured $1.58 million in new funding since 1 April 2026, following the conversion of options exercisable at $0.025 and $0.05 per option.
Error: Contact form not found.
Recent Comments